Major improvements in the field of radiotherapy planning such as stereotactic radiation therapy, have recently been performed, aiming to the development of personalized therapeutic strategies in patients with biochemical failure of prostate cancer.
However, this needs an early and accurate location of sites of recurrence. Development of multimodality magnetic resonance imaging (MRI) and positron emission tomography (PET) permits to consider this objective. Thus, it is worthwhile to apprehend the respective performance of these imaging techniques in order to rationalize their use. We propose a review of the recent literature organized by technique and by location, regarding the performance of multimodality MRI and PET for restaging of patients with biochemical failure of prostate cancer initially treated with curative intent.
Cochet A, Kanoun S, Humbert O, Walker PM, Cormier L, Créhange G, Brunotte F. Are you the author?
Service de médecine nucléaire, centre Georges-François-Leclerc, 1, rue Professeur-Marion, 21079 Dijon cedex, France; Le2i laboratoire électronique, informatique et image, UMR 6306, Université de Bourgongne, BP 27877, 21078 Dijon cedex, France; Service de spectroscopie RMN, CHU de Dijon, BP 77908, 21079 Dijon cedex, France; Service d'urologie, CHU de Dijon, BP 77908, 21079 Dijon cedex, France; Service de radiothérapie, centre Georges-François Leclerc, 1, rue Professeur-Marion, 21079 Dijon cedex, France.
Reference: Cancer Radiother. 2014 Oct;18(5-6):509-16.
Article in French.